SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020459
Filing Date
2018-08-08
Accepted
2018-08-08 16:06:56
Documents
74
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akba-10q_20180630.htm 10-Q 2211586
2 EX-10.1 akba-ex101_13.htm EX-10.1 151942
3 EX-31.1 akba-ex311_9.htm EX-31.1 17692
4 EX-31.2 akba-ex312_8.htm EX-31.2 17690
5 EX-32.1 akba-ex321_6.htm EX-32.1 12246
6 EX-99.1 akba-ex991_7.htm EX-99.1 132142
7 GRAPHIC g0yseykbfqrb000001.jpg GRAPHIC 28819
8 GRAPHIC gbbystfzxkr3000001.jpg GRAPHIC 41525
  Complete submission text file 0001564590-18-020459.txt   9672003

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT akba-20180630.xml EX-101.INS 2259181
10 XBRL TAXONOMY EXTENSION SCHEMA akba-20180630.xsd EX-101.SCH 73255
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20180630_cal.xml EX-101.CAL 53326
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20180630_def.xml EX-101.DEF 245947
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20180630_lab.xml EX-101.LAB 465011
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20180630_pre.xml EX-101.PRE 387240
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 181001383
SIC: 2834 Pharmaceutical Preparations